Tuxarin ER FDA Approval History
FDA Approved: Yes (First approved June 22, 2015)
Brand name: Tuxarin ER
Generic name: chlorpheniramine and codeine
Dosage form: Extended Release Tablets
Company: Spriaso LLC
Treatment for: Cough, Cold Symptoms
Tuxarin ER (codeine and chlorpheniramine) is a long acting narcotic antitussive and antihistamine combination for the treatment of cough and cold symptoms.
Development timeline for Tuxarin ER
|Jul 1, 2015
|Approval Spriaso Announces FDA Approval of Long Acting Tuxarin ER (codeine and chlorpheniramine)
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.